Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company): 3 sponsored US clinical trials, none currently recruiting.
Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) sponsors 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Bacterial Infections, with 1 trials.
Upper-quartile sponsor footprint
Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
3 total, page 1 of 1
Evaluating the Plasma, Epithelial Lining, and Alveolar Macrophage Concentrations of Intravenous Carbavance™ (RPX2014/RPX7009) in Healthy Adult Subjects
NCT02073812
The Safety and Pharmacokinetics of Carbavance™ (RPX2014/RPX7009) in Subjects With Renal Insufficiency
NCT02020434
Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects
NCT01702649
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
Therapeutic Areas
How the Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) early-phase archive is shaped
3 indexed studies, none listed as recruiting (0% open); 3 completed (100%).
Phase mix: 0 late (III/IV) vs 3 early (I/II) (early-phase heavy).
Top condition: Bacterial Infections (1 trial), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company): archived-pipeline peers nationwide
Peers matched on 3 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 archived trials
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
- 3EO Health · 0% recruiting · 2 trials
Related
What to do with this Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) page
3 registered trials is a research-attention snapshot, not an endorsement of Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) or any single study.
- None of Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)'s trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Bacterial Infections is the condition Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Bacterial Infections trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) pipeline card: 3 registered trials from official public datasets.Report a data error.